BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29367687)

  • 1. The association between short-term response and long-term survival for cervical cancer patients undergoing neoadjuvant chemotherapy: a system review and meta-analysis.
    Kong SY; Huang K; Zeng C; Ma X; Wang S
    Sci Rep; 2018 Jan; 8(1):1545. PubMed ID: 29367687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early response to neoadjuvant chemotherapy helps decrease recurrence rate of cervical cancer: a systematic review and meta-analysis.
    Hou Q; Shen J; Zhou S; Wei J; Wu M; Chen Q; Yan W; Zhang P; Yue Q; Wang S; Huang K
    Ann Palliat Med; 2021 Jun; 10(6):6092-6103. PubMed ID: 34118837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients.
    Chen Z; Shi Y; Wang S; Lu Q
    Oncotarget; 2017 Aug; 8(35):59609-59617. PubMed ID: 28938664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer.
    Li X; Huang K; Zhang Q; Shen J; Zhou H; Yang R; Wang L; Liu J; Zhang J; Sun H; Jia Y; Du X; Wang H; Deng S; Ding T; Jiang J; Lu Y; Li S; Wang S; Ma D
    Oncotarget; 2016 Dec; 7(52):87485-87495. PubMed ID: 27557523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria.
    Hu T; Li S; Chen Y; Shen J; Li X; Huang K; Yang R; Wu L; Chen Z; Jia Y; Wang S; Cheng X; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Xu H; Xu J; Zhang Q; Xi L; Deng D; Wang H; Wang S; Lv W; Wang C; Xie X; Ma D
    Eur J Cancer; 2012 Oct; 48(15):2353-60. PubMed ID: 22503395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer.
    He L; Wu L; Su G; Wei W; Liang L; Han L; Kebria M; Liu P; Chen C; Yu Y; Zhong M; Wang W
    Gynecol Oncol; 2014 Aug; 134(2):419-25. PubMed ID: 24918866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.
    Zhou J; Li X; Huang K; Jia Y; Tang F; Sun H; Zhang Y; Zhang Q; Ma D; Li S
    PLoS One; 2016; 11(2):e0149534. PubMed ID: 26901776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer: A meta-analysis.
    Zhu Y; Yang J; Zhang X; Chen D; Zhang S
    Medicine (Baltimore); 2018 Apr; 97(17):e0530. PubMed ID: 29703026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy.
    Huang K; Sun H; Chen Z; Li X; Wang S; Zhao X; Tang F; Jia Y; Hu T; Du X; Wang H; Lu Z; Huang J; Gui J; Wang X; Zhou S; Wang L; Zhang J; Guo L; Yang R; Shen J; Zhang Q; Li S; Wang S
    Sci Rep; 2016 Jun; 6():28278. PubMed ID: 27325186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
    J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer.
    Bogani G; Sabatucci I; Maltese G; Lecce F; Signorelli M; Martinelli F; Chiappa V; Indini A; Leone Roberti Maggiore U; Borghi C; Fucà G; Ditto A; Raspagliesi F; Lorusso D
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():41-45. PubMed ID: 27888705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
    Bogani G; Ditto A; Martinelli F; Signorelli M; Chiappa V; Lopez C; Indini A; Leone Roberti Maggiore U; Sabatucci I; Lorusso D; Raspagliesi F
    Int J Gynecol Cancer; 2017 Mar; 27(3):514-522. PubMed ID: 28129238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
    Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes.
    Liu Y; Zhang KC; Huang XH; Xi HQ; Gao YH; Liang WQ; Wang XX; Chen L
    World J Gastroenterol; 2018 Jan; 24(2):257-265. PubMed ID: 29375211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
    Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
    Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
    Li J; Wu MF; Lu HW; Zhang BZ; Wang LJ; Lin ZQ
    PLoS One; 2016; 11(11):e0166612. PubMed ID: 27851819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis.
    Ye Q; Yuan HX; Chen HL
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1887-98. PubMed ID: 24022086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.